News

Filter

Current filters:

Compugen

Bayer inks multi-million dollar cancer immunotherapy deal

05-08-2013

Germany's largest pharma company Bayer (BAYN: DE) has entered into a new oncology collaboration and license…

BayerCompugenLicensingOncologyPharmaceuticalResearch

Compugen and Merck Serono set up biomarker company Neviah Genomics

25-06-2012

German drug major Merck KGaA's (MRK: DE) Merck Serono division and Israel-based Compugen (Nasdaq: CGEN)…

BiotechnologyCompugenMerck KGaAMerck SeronoMergers & AcquisitionsResearch

BioLineRx inks deal with Compugen

14-12-2011

Israeli biopharma company BioLineRx (TASE: BLRX) has entered into a collaboration with fellow Israel-based…

BioLineRxBiotechnologyCardio-vascularCompugenInflammatory diseasesLicensingOncologyPharmaceuticalResearch

Compugen links with DiscoveRx on novel peptide ligands for GPCR drug targets

01-12-2011

Israel’s Compugen (Nasdaq: CGEN) and USA-based DiscoveRx have entered into a partnership for the…

Cardio-vascularCompugenDiscoveRxInflammatory diseasesPharmaceuticalResearch

COMPANY SPOTLIGHT

Menarini

Back to top